<DOC>
	<DOCNO>NCT00929565</DOCNO>
	<brief_summary>Some risk factor bleed follow bronchoscopy malignancy immunocompromised state . The etiology remain uncertain . The investigator suspect individual malignancy abnormality involve certain factor influence coagulation pathway . The investigator plan measure factor prior bronchoscopy .</brief_summary>
	<brief_title>Urokinase Like Plasminogen Activator Levels Patients Undergoing Bronchoscopy</brief_title>
	<detailed_description>This prospective observational study look coagulation factor individual lung cancer . We look BAL plasma . We would like see difference level reason behind high incidence hemoptysis patient lung cancer .</detailed_description>
	<mesh_term>Hemoptysis</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<criteria>Any patient schedule undergo bronchoscopy Patients evidence coagulopathy either iatrogenic result disease process coagulopathy define elevated prothrombin time , activate partial thromboplastin time platelet count le 100,000 Patients schedule undergo bronchoalveolar lavage ( BAL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>hemoptysis</keyword>
</DOC>